SUVEN — Suven Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹21.98bn
- IN₹19.59bn
- IN₹116.93m
Annual cashflow statement for Suven Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,064 | -775 | -1,220 | -1,183 | -1,061 |
| Depreciation | |||||
| Non-Cash Items | -122 | -62.2 | -46.6 | -10.9 | 45.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -199 | -158 | -44.5 | 104 | 131 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,346 | -960 | -1,275 | -1,031 | -826 |
| Capital Expenditures | -23.9 | -63 | -198 | -28.9 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1,486 | 621 | -24.6 | -2,578 | 616 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1,462 | 558 | -222 | -2,606 | 616 |
| Financing Cash Flow Items | -4.87 | -8.15 | -3.95 | -2.62 | -1.58 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28.1 | 349 | 1,457 | 3,955 | -10.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 144 | -53.3 | -40.7 | 317 | -221 |